Fidelity Investments’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,146,049
| Closed | -$123M | – | 5655 |
|
|
2023
Q1 | $123M | Buy |
1,146,049
+391,329
| +52% | +$42M | 0.01% | 916 |
|
|
2022
Q4 | $83M | Buy |
754,720
+337,481
| +81% | +$37.1M | 0.01% | 1043 |
|
|
2022
Q3 | $24.6M | Buy |
417,239
+64,054
| +18% | +$3.78M | ﹤0.01% | 1546 |
|
|
2022
Q2 | $9.97M | Buy |
353,185
+51,488
| +17% | +$1.45M | ﹤0.01% | 1969 |
|
|
2022
Q1 | $11.4M | Buy |
301,697
+497
| +0.2% | +$18.8K | ﹤0.01% | 2058 |
|
|
2021
Q4 | $11.9M | Hold |
301,200
| – | – | ﹤0.01% | 2043 |
|
|
2021
Q3 | $7.14M | Sell |
301,200
-111,600
| -27% | -$2.65M | ﹤0.01% | 2253 |
|
|
2021
Q2 | $10.1M | Sell |
412,800
-143,400
| -26% | -$3.52M | ﹤0.01% | 2101 |
|
|
2021
Q1 | $10.2M | Buy |
+556,200
| New | +$10.2M | ﹤0.01% | 2030 |
|